These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33986256)

  • 1. Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2.
    Wang P; Gong S; Pan J; Wang J; Zou D; Xiong S; Zhao L; Yan Q; Deng Y; Wu N; Liao B
    Cell Death Discov; 2021 May; 7(1):103. PubMed ID: 33986256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
    Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
    Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions.
    Wang P; Gong S; Liao B; Pan J; Wang J; Zou D; Zhao L; Xiong S; Deng Y; Yan Q; Wu N
    J Cancer; 2022; 13(1):1-14. PubMed ID: 34976166
    [No Abstract]   [Full Text] [Related]  

  • 5. HIF1α and HIF2α regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions.
    Xiong S; Wang D; Tang Y; Lu S; Huang L; Wu Z; Lei S; Liang G; Yang D; Li D; Li Y
    Gene; 2023 May; 863():147288. PubMed ID: 36804853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbaric Oxygen Therapy Adjuvant Chemotherapy and Radiotherapy through Inhibiting Stemness in Glioblastoma.
    Yuen CM; Tsai HP; Tseng TT; Tseng YL; Lieu AS; Kwan AL; Chang AYW
    Curr Issues Mol Biol; 2023 Oct; 45(10):8309-8320. PubMed ID: 37886967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro.
    Zembrzuska K; Ostrowski RP; Matyja E
    Oncol Rep; 2019 May; 41(5):2703-2716. PubMed ID: 30896865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of HIF1α- and HIF2α-regulated BNIP3 in hypoxia-induced injury of neurons.
    Zhu L; Qi B; Hou D
    Pathol Res Pract; 2019 Apr; 215(4):822-827. PubMed ID: 30704780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
    Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
    Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
    Iida H; Suzuki M; Goitsuka R; Ueno H
    Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.
    Smeyne M; Sladen P; Jiao Y; Dragatsis I; Smeyne RJ
    Neuroscience; 2015 Jun; 295():23-38. PubMed ID: 25796140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
    Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
    Front Immunol; 2019; 10():2762. PubMed ID: 31866995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
    Yang X; Yang S; Wang C; Kuang S
    J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
    Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
    Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.